Trademark: 79357367
Word
SATIVEX
Status
Pending
Status Code
641
Status Date
Friday, April 26, 2024
Serial Number
79357367
Mark Type
4
Filing Date
Wednesday, November 16, 2022

Trademark Owner History
GW Research Limited - 1st New Owner Before Publication
GW Pharma Limited - Original Applicant

Classifications
5 Pharmaceutical and veterinary preparations for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; pure extracts of medicinal plants and herbs; foodstuffs for medicinal purposes, namely, dietetic foods adapted for medical use; herb teas for medicinal purposes

Trademark Events
Dec 8, 2022
Sn Assigned For Sect 66a Subseq Desig From Ib
Dec 12, 2022
New Application Office Supplied Data Entered
Dec 16, 2022
Application Filing Receipt Mailed
Jan 5, 2023
International Registration Renewed
Aug 30, 2023
Assigned To Examiner
Sep 7, 2023
Non-Final Action Written
Sep 8, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Sep 26, 2023
Refusal Processed By Mpu
Sep 26, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Oct 16, 2023
Refusal Processed By Ib
Mar 26, 2024
Teas Response To Office Action Received
Mar 26, 2024
Correspondence Received In Law Office
Mar 26, 2024
Teas/Email Correspondence Entered
Apr 26, 2024
Non-Final Action Written
Apr 26, 2024
Non-Final Action E-Mailed
Apr 26, 2024
Notification Of Non-Final Action E-Mailed
May 8, 2024
Notification Of Possible Opposition Sent To Ib
May 8, 2024
Notification Of Possible Opposition Created, To Be Sent To Ib
May 31, 2024
Change Of Owner Received From Ib
Jun 2, 2024
Refusal Processed By Ib
Jun 11, 2024
Notification Of Possible Opposition - Processed By Ib

Trademark Alertz updated from USPTO on 2030-01-24